The Therapeutic Goods Administration (TGA) urges consumers and health professionals to report adverse events experienced in association with transvaginal meshes. From July 2012 to June 2016, the TGA received 99 adverse events reports involving transvaginal meshes. The most frequently reported adverse events were pain and erosion. Adverse events associated with meshes may include: punctures or lacerations of vessels, nerves, structures or organs, including the bladder, urethra or bowel; transitory local irritation at the wound site; mesh extrusion, exposure, or erosion into the vagina or other structures or organs; acute and/or chronic pain; voiding dysfunction; pain during intercourse; neuromuscular problems including acute and/or chronic pain in the groin, thigh, leg, pelvic and/or abdominal area; recurrence of incontinence; bleeding including haemorrhage, or haematoma; mesh migration; and allergic reaction.
Sue Turner is one of many women in Australia experiencing health problems following a transvaginal mesh implant.